681 related articles for article (PubMed ID: 7679553)
41. [Cells of the phenotype HNK-1 + (CD 57 +) in reactive adenopathies, lymphomas and Hodgkin's disease].
Merlio JP; Caveriviere P; al Saati T; Coindre JM; de Mascarel A; Delsol G
Ann Pathol; 1990; 10(3):166-73. PubMed ID: 1696823
[TBL] [Abstract][Full Text] [Related]
42. High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma.
van den Berg A; Visser L; Poppema S
Am J Pathol; 1999 Jun; 154(6):1685-91. PubMed ID: 10362793
[TBL] [Abstract][Full Text] [Related]
43. Nodular lymphocyte predominance Hodgkin's disease: a monoclonal or polyclonal B-cell disorder?
Pan LX; Diss TC; Peng HZ; Norton AJ; Isaacson PG
Blood; 1996 Mar; 87(6):2428-34. PubMed ID: 8630407
[TBL] [Abstract][Full Text] [Related]
44. T-cell-rich B-cell lymphomas. A clinicopathologic study of 19 cases.
Macon WR; Williams ME; Greer JP; Stein RS; Collins RD; Cousar JB
Am J Surg Pathol; 1992 Apr; 16(4):351-63. PubMed ID: 1373580
[TBL] [Abstract][Full Text] [Related]
45. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
Miettinen M
Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
[TBL] [Abstract][Full Text] [Related]
46. The interrelationship of Hodgkin's disease and non-Hodgkin's lymphomas--lessons learned from composite and sequential malignancies.
Jaffe ES; Zarate-Osorno A; Medeiros LJ
Semin Diagn Pathol; 1992 Nov; 9(4):297-303. PubMed ID: 1480852
[TBL] [Abstract][Full Text] [Related]
47. Composite B-cell and T-cell lymphoma arising 24 years after nodular lymphocyte predominant Hodgkin's disease.
Hancock JC; Wells A; Halling KC; Tilashalski K; Conner MG; Johns C; Listinsky CM
Ann Diagn Pathol; 1999 Feb; 3(1):23-34. PubMed ID: 9990110
[TBL] [Abstract][Full Text] [Related]
48. T-cell-rich B large-cell lymphoma simulating lymphocyte-rich Hodgkin's disease.
McBride JA; Rodriguez J; Luthra R; Ordóñez NG; Cabanillas F; Pugh WC
Am J Surg Pathol; 1996 Feb; 20(2):193-201. PubMed ID: 8554109
[TBL] [Abstract][Full Text] [Related]
49. Workshop report on Hodgkin's disease and related diseases ('grey zone' lymphoma).
Rüdiger T; Jaffe ES; Delsol G; deWolf-Peeters C; Gascoyne RD; Georgii A; Harris NL; Kadin ME; MacLennan KA; Poppema S; Stein H; Weiss LE; Müller-Hermelink HK
Ann Oncol; 1998; 9 Suppl 5():S31-8. PubMed ID: 9926235
[TBL] [Abstract][Full Text] [Related]
50. Monoclonal antibodies in the diagnosis of Hodgkin's disease. The search for a rational panel.
Chittal SM; Caverivière P; Schwarting R; Gerdes J; Al Saati T; Rigal-Huguet F; Stein H; Delsol G
Am J Surg Pathol; 1988 Jan; 12(1):9-21. PubMed ID: 2827535
[TBL] [Abstract][Full Text] [Related]
51. Distinctive expression pattern of the BCL-6 protein in nodular lymphocyte predominance Hodgkin's disease.
Falini B; Bigerna B; Pasqualucci L; Fizzotti M; Martelli MF; Pileri S; Pinto A; Carbone A; Venturi S; Pacini R; Cattoretti G; Pescarmona E; Lo Coco F; Pelicci PG; Anagnastopoulos I; Dalla-Favera R; Flenghi L
Blood; 1996 Jan; 87(2):465-71. PubMed ID: 8555467
[TBL] [Abstract][Full Text] [Related]
52. The relationship between Hodgkin's disease and non-Hodgkin's lymphoma.
Harris NL
Semin Diagn Pathol; 1992 Nov; 9(4):304-10. PubMed ID: 1480853
[TBL] [Abstract][Full Text] [Related]
53. [Proliferating cells in Hodgkin's disease].
Schmid C; Isaacson PG
Verh Dtsch Ges Pathol; 1992; 76():151-4. PubMed ID: 1283248
[TBL] [Abstract][Full Text] [Related]
54. [Histopathological diagnosis of Hodgkin's disease].
Delsol G
Rev Prat; 1998 May; 48(10):1060-4. PubMed ID: 9781148
[TBL] [Abstract][Full Text] [Related]
55. An evaluation of the utility of anti-granulocyte and anti-leukocyte monoclonal antibodies in the diagnosis of Hodgkin's disease.
Dorfman RF; Gatter KC; Pulford KA; Mason DY
Am J Pathol; 1986 Jun; 123(3):508-19. PubMed ID: 3717303
[TBL] [Abstract][Full Text] [Related]
56. Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin's disease. Evidence for a dendritic or B cell derivation?
Pinkus GS; Pinkus JL; Langhoff E; Matsumura F; Yamashiro S; Mosialos G; Said JW
Am J Pathol; 1997 Feb; 150(2):543-62. PubMed ID: 9033270
[TBL] [Abstract][Full Text] [Related]
57. Pathologic features of nodular lymphocyte predominance Hodgkin's disease in extranodal sites.
Chang KL; Kamel OW; Arber DA; Horyd ID; Weiss LM
Am J Surg Pathol; 1995 Nov; 19(11):1313-24. PubMed ID: 7573694
[TBL] [Abstract][Full Text] [Related]
58. Lymphocyte predominance Hodgkin's disease--an immunohistochemical study.
Nicholas DS; Harris S; Wright DH
Histopathology; 1990 Feb; 16(2):157-65. PubMed ID: 2323737
[TBL] [Abstract][Full Text] [Related]
59. Nodular lymphocyte predominance Hodgkin's disease. A distinct clinicopathological entity.
Mason DY; Banks PM; Chan J; Cleary ML; Delsol G; de Wolf Peeters C; Falini B; Gatter K; Grogan TM; Harris NL
Am J Surg Pathol; 1994 May; 18(5):526-30. PubMed ID: 8172327
[TBL] [Abstract][Full Text] [Related]
60. T-bet, a T cell-associated transcription factor, is expressed in Hodgkin's lymphoma.
Dorfman DM; Hwang ES; Shahsafaei A; Glimcher LH
Hum Pathol; 2005 Jan; 36(1):10-5. PubMed ID: 15712176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
